Shilpa Medicare Limited (BOM:530549)

India · Delayed Price · Currency is INR

499.30

+1.15 (0.23%)

At close: Jun 1, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals	15.39B	12.88B	11.53B	10.52B	11.47B
Pharmaceuticals Growth	19.49%	11.69%	9.64%	-8.31%	27.21%
Total	15.39B	12.88B	11.53B	10.52B	11.47B
Total Growth	19.49%	11.69%	9.64%	-8.31%	27.21%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	4.80B	5.35B	5.11B	4.88B
India Growth	-10.19%	4.79%	4.62%	47.28%
USA	2.35B	1.80B	1.64B	1.91B
USA Growth	30.08%	10.02%	-14.16%	43.66%
Europe	3.01B	2.25B	2.13B	3.25B
Europe Growth	33.46%	5.76%	-34.46%	24.66%
Rest of The World	2.71B	2.11B	1.62B	1.41B
Rest of The World Growth	28.31%	29.76%	14.94%	-19.67%
Total	12.86B	11.52B	10.50B	11.46B
Total Growth	11.71%	9.66%	-8.33%	27.12%

Source: S&P Global Market Intelligence.